Immunogenicity, Safety, and Tolerability of a Plant-Derived Quadrivalent VLP Influenza Vaccine in Elderly Adults

Clinical trial NCT02831751 · COMPLETED

Trial details

NCT number: NCT02831751
Sponsor: Medicago
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Virus Diseases RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections

Start date: 2016-04-01
Primary completion: 2016-07-01
Enrollment: 1001

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.